Entegris (ENTG) has drawn fresh attention after announcing a cross licensing agreement with JSR and Inpria that ends a patent dispute and sets up cooperation on EUV photoresist and filtration technology for advanced chips.
See our latest analysis for Entegris.
The cross licensing deal has arrived on the back of strong momentum, with Entegris delivering a 90 day share price return of 40.24% and a 1 year total shareholder return of 108.81%. This suggests that investors are increasingly willing to pay a premium for its semiconductor materials exposure.
If this kind of move in chip related materials has your attention, it could be a good moment to broaden your search using our 48 AI infrastructure stocks
After such a strong run, Entegris now trades slightly above the average analyst price target and its own intrinsic estimate, raising a key question for you: is there still an opportunity here, or is the market already pricing in future growth?
At a last close of $162.79 versus a narrative fair value of $160.60, the current price sits slightly above the modelled estimate. This estimate hinges heavily on how the wafer fab equipment cycle plays out and how much earnings power Entegris can retain.
Investments and leadership in advanced materials for next-generation nodes, including CMP slurries, selective etch, and deposition materials, position Entegris to capitalize on upcoming node transitions (e.g., advanced logic, 3D NAND, HBM) and increasing semiconductor complexity, supporting higher ASPs and improved gross margins.
Curious what kind of revenue mix, margin uplift, and earnings multiple this narrative assumes to support that valuation gap over time? The full storyline connects capacity ramps, higher value materials and a richer profit profile into one compact fair value playbook.
Result: Fair Value of $160.60 (OVERVALUED)
Have a read of the narrative in full and understand what's behind the forecasts.
However, the story can change quickly if wafer fab equipment spending weakens or if high debt and interest costs begin to reduce Entegris’ flexibility.
Wall Street's queuing for one rocket. While SpaceX counts down to its IPO, other companies tied to the new space race are already in orbit. → 20 Compelling Space Companies watchlist · Global Space Race Investing Ideas screener · Scan the sector by valuation on Rocket Lab's valuation page.
Given the mix of optimism and caution in this story, it can be useful to act promptly and review the numbers independently before opinions solidify, starting with the 1 key reward and 2 important warning signs.
If Entegris has sharpened your focus, do not stop here. Broaden your opportunity set now so you are not relying on a single stock story.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com
Contact Us
Contact Number :+852 3852 8500
English